The largest database of trusted experimental protocols

8 protocols using alexa fluor 594 conjugated isolectin gs ib4

1

RPE-Choroid-Sclera Complex Analysis Post Laser

Check if the same lab product or an alternative is used in the 5 most similar protocols
On days 3, 7, and 14 after laser photocoagulation, RPE-choroid-sclera complexes were surgically isolated, fixed with 4% paraformaldehyde for 1 h, and then incubated with a blocking buffer containing PBS, 0.5% Triton X-100, and 5% bovine serum albumin for 4 h at 4°C. The complexes were then incubated with Alexa Fluor®-594 conjugated isolectin (GS-IB4; Invitrogen, Carlsbad, CA, USA). The CNV lesions were imaged with a confocal microscope (FV 1000; Olympus), and fluorescent signals were quantified (Image-Pro Plus; Media Cybernetics, Inc., Rockville, MD, USA) [9 (link)].
+ Open protocol
+ Expand
2

Endothelial Tube Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the tube formation assay, the cells separated by MACS were plated on 4-well slides (Iwaki Glass, Tokyo, Japan) coated thickly with BD Matrigel Basement Membrane Matrix (250 μL, Becton-Dickinson Co., Franklin Lakes, NJ) at 3 × 104 cells/cm2, following culture for 48 hours in EBM-2 medium with EGM-2 Bulletkit (LONZA, Basel, Switzerland). After the culture, cells were fixed with 4% PFA and stained with Alexa Fluor 594 conjugated isolectin GS-IB4 (Invitrogen) and DAPI (Merck). The tube formations were assessed with a fluorescence microscope (BX51, Olympus Optical) and images were obtained by a CCD camera (DP70, Olympus Optical).
+ Open protocol
+ Expand
3

Immunolabeling of Retinal Vasculature

Check if the same lab product or an alternative is used in the 5 most similar protocols
The isolated retinal vasculature was snap frozen in optimal cutting temperature (OCT) solution. Cryostat sections (10 μm) were obtained, mounted on glass slides and permeabilized with 1% Triton for 10 min and blocked in 10% normal goat serum for 1 h. Sections were then incubated with anti-p16INK4A antibody (Abcam, Cambridge, MA, USA; Cat. # ab189034; 1:50) and Alexa Fluor 594-conjugated isolectin GS-IB4 (Invitrogen, Carlsbad, CA, USA; Cat. # I21413; 1:200) at 4 °C overnight. On the next day, the sections were washed three times with phosphate-buffered saline (PBS) and were then incubated for 1 h at room temperature with Alexa Fluor 488-conjugated secondary antibody (Invitrogen, Carlsbad, CA, USA; Cat. # A11034; 1:400) that was washed in PBS, and covered with mounting medium containing 4′,6′-diamino-2-phenylindole (DAPI) for counterstaining (Vectashield; Vector Laboratories, Burlingame, CA, USA; Cat. # H-1200). Images from three to four samples per group were taken using Zeiss Axioplan2 Imager Microscope (Zeiss, San Diego, CA, USA). The results were analyzed by measuring the fluorescence intensity of p16 immunolabeling using ImageJ software.
+ Open protocol
+ Expand
4

Retinal Angiogenesis and Vascular Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Retinas were fixed in 10% neutral buffered formalin (Sigma), embedded in paraffin, and sectioned. After quenching endogenous peroxidase activity and blocking with 10% normal horse serum, the sections were incubated with primary IgG against phospho-cKit (p-cKit; Cell Signaling Technology), p-eNOS (Cell Signaling Technology), or CD31 (DakoCytomation, Carpinteria, CA, USA), followed by the appropriate fluorescence-conjugated secondary IgG. For whole-mount retina staining, samples were blocked with 5% bovine serum albumin and 5% normal donkey serum in 0.5% Triton X-100, then stained with a primary IgG against VE-cadherin (BD Biosciences). The whole mounts were incubated with the appropriate Alexa Fluor 488conjugated secondary IgG (Invitrogen) and further stained with Alexa Fluor 594-conjugated isolectin GS-IB4 (Invitrogen) overnight. The number of sections examined ranged from 6 to 10 per group.
+ Open protocol
+ Expand
5

Quantifying Muscle Capillary Density

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ischemic gastrocnemius muscle and soleus muscle were fixed with 4% paraformaldehyde and embedded with paraffin. Paraffin sections were cut at 5 μm and stained with Alexa Fluor® 594 conjugated isolectin GS-IB4 (Thermo Scientific, Waltham, MA) to evaluate the capillary density. The number of capillaries were calculated in randomly selected fields for a total of 20 different fields ( × 40 magnification) per section and 3 sections per animal. The capillary density was expressed as capillary number per muscle fiber.
+ Open protocol
+ Expand
6

Quantifying EPC Homing and Angiogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the homing and incorporation of EPCs in the ischemic muscle, ischemic gastrocnemius muscle and/or soleus muscle were embedded in OCT medium for frozen section. The GFP positive EPCs were counted in randomly selected fields for a total of 20 different fields (×40 magnification) per section and 3 sections per animal. The EPC incorporation was expressed as the percentage of GFP positive capillaries.
The extent of angiogenesis and arteriogenesis at day 28 post ischemic surgery was assessed by measuring capillary density in gastrocnemius muscle and/or soleus muscle using isolectin B4 staining, and arteriole area in adductor muscle. Ischemic gastrocnemius muscle, soleus muscle and/or adductor tissues were fixed with 4% paraformaldehyde and embedded with paraffin. Paraffin sections were cut at 5 μm and stained with Alexa Fluor® 594 conjugated isolectin GS-IB4 (Thermo Scientific, Waltham, MA)or anti-alpha smooth muscle actin (α-SMA) antibody (Abcam) to evaluate the capillary density and arteriole area respectively. The number of capillaries or arteriole area were calculated in randomly selected fields for a total of 20 different fields (×40 magnification) per section and 3 sections per animal. The capillary density was expressed as capillary number per muscle fiber, and the arteriole area was expressed as α-SMA positive arteriole area per fiber and normalized by control.
+ Open protocol
+ Expand
7

Retinal Vascular Leakage Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
FITC-conjugated dextran (70 kDa, 0.1 mg/g; Thermo Fisher Scientific; D1822) was injected retro-orbitally and allowed to circulate for 1 hour. Mice were then euthanized, and eyes were enucleated. Eyes were lightly fixed with 4% paraformaldehyde (PFA) for 15 min at room temperature, and retinas were dissected and flat-mounted. Whole-mounted retinas were imaged using confocal microscopy (LSM 880; Zeiss, Oberkochen, Germany). The fluorescence intensity of FITC-dextran was analyzed with Zeiss microscope software ZEN Intellesis to segment and quantify vascular leakage from retinal vessels based on previous protocols (60 ). Retinas were costained with Alexa Fluor 594–conjugated isolectin GS-IB4 (Thermo Fisher Scientific; I21413).
+ Open protocol
+ Expand
8

Creatine Monohydrate Effects on Retinal Angiogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
In OIR, mouse pups (C57BL/6J, male and female) were orally gavaged with creatine monohydrate (500 mg/kg; C3630; Sigma-Aldrich, St Louis, MO, USA) or PBS (control; 10010–023; Thermo Fisher Scientific) daily, from P12 to P16. Five mice each were allocated to the creatine treatment group and to the vehicle group. At P17, eyes were enucleated and retinas were stained with Alexa Fluor 594-conjugated isolectin GS-IB4 (10 μg/ml; I21413; Thermo Fisher Scientific), as described [24 (link)]. Then, retinas were visualised using anF epifluorescence microscope (AxioObserver.Z1; Carl Zeiss Microscopy, Jena, Germany). Mice weighing less than 5.0 g were excluded from this study [25 (link)]. At P17, the areas of retinal NV and vaso-obliteration (VO) were quantified as previously described [26 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!